These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 216980)

  • 1. Atopic dermatitis: clinical and immunologic aspects and treatment.
    Kaplan RJ; Rosenberg EW
    Postgrad Med; 1978 Dec; 64(6):52-6. PubMed ID: 216980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis.
    Hanifin JM
    J Am Acad Dermatol; 1982 Jan; 6(1):1-13. PubMed ID: 7045169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis.
    Fukuie T; Nomura I; Horimukai K; Manki A; Masuko I; Futamura M; Narita M; Ohzeki T; Matsumoto K; Saito H; Ohya Y
    Br J Dermatol; 2010 Nov; 163(5):1127-9. PubMed ID: 20545693
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis.
    Kaplan RJ; Daman L; Rosenberg EW; Feigenbaum S
    Arch Dermatol; 1978 Jan; 114(1):60-2. PubMed ID: 339846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathology of atopic dermatitis].
    Wüthrich B
    Monatsschr Kinderheilkd; 1984 Jun; 132(6):426-31. PubMed ID: 6088971
    [No Abstract]   [Full Text] [Related]  

  • 6. Atopic dermatitis: beyond the itch that rashes.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2005 May; 25(2):333-51, vii. PubMed ID: 15878459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic and clinical aspects of atopic dermatitis.
    Hanifin JM
    Ann Allergy; 1984 Jun; 52(6):386-95. PubMed ID: 6145376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis.
    Kanda N; Enomoto U; Watanabe S
    J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.
    Yamamoto M; Haruna T; Yasui K; Takahashi H; Iduhara M; Takaki S; Deguchi M; Arimura A
    Allergol Int; 2007 Jun; 56(2):139-48. PubMed ID: 17460441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebound phenomenon to systemic corticosteroid in atopic dermatitis.
    Forte WC; Sumita JM; Rodrigues AG; Liuson D; Tanaka E
    Allergol Immunopathol (Madr); 2005; 33(6):307-11. PubMed ID: 16371217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J; Remitz A; Virtanen H; Reitamo S
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal function following topical steroid treatment in children with atopic dermatitis.
    Patel L; Clayton PE; Addison GM; Price DA; David TJ
    Br J Dermatol; 1995 Jun; 132(6):950-5. PubMed ID: 7662574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.
    Jorizzo J; Levy M; Lucky A; Shavin J; Goldberg G; Dunlap F; Hinds A; Strelka L; Baker M; Tuley M
    J Am Acad Dermatol; 1995 Jul; 33(1):74-7. PubMed ID: 7601950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
    Amrol D
    South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current clinical practice in atopic dermatitis.
    Odedra KM
    Nurs Stand; 2014 Aug; 28(49):45-51. PubMed ID: 25095959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hypothalamic-pituitary-adrenal axis in patients with atopic dermatitis.
    ; Kanwar AJ; Bhansali A; Parsad D
    Indian J Dermatol Venereol Leprol; 2011; 77(3):288-93. PubMed ID: 21508566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.